BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 1285 hits Enz. Inhib. hit(s) with Target = 'Formyl peptide receptor 1'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
N-formyl peptide receptor 1


(Homo sapiens (Human))
BDBM454202
PNG
(US10717708, Example 183)
Show SMILES CC(C)(C)NS(=O)(=O)c1ccccc1-c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(Cl)cc2)C1=O
Show InChI InChI=1S/C28H31ClN4O4S/c1-28(2,3)32-38(36,37)25-9-5-4-7-23(25)19-10-16-22(17-11-19)33-18-6-8-24(26(33)34)31-27(35)30-21-14-12-20(29)13-15-21/h4-5,7,9-17,24,32H,6,8,18H2,1-3H3,(H2,30,31,35)/t24-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 0.560n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US10717708 (2020)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM450320
PNG
(US10676431, Example 83)
Show SMILES CP(C)(=O)c1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1C(F)(F)F
Show InChI InChI=1S/C26H22ClF5N3O3P/c1-39(2,38)21-6-4-3-5-15(21)16-8-10-20(23(29)22(16)26(30,31)32)35-12-11-19(24(35)36)34-25(37)33-18-9-7-14(27)13-17(18)28/h3-10,13,19H,11-12H2,1-2H3,(H2,33,34,37)/t19-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.990n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...


US Patent US10676431 (2020)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM50050929
PNG
(2-((S)-2-{(S)-2-[3-(4-Methoxy-phenyl)-ureido]-4-me...)
Show SMILES COc1ccc(NC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)NC(Cc2ccccc2)C(O)=O)cc1
Show InChI InChI=1S/C28H38N4O6S/c1-18(2)16-23(26(34)31-24(27(35)36)17-19-8-6-5-7-9-19)30-25(33)22(14-15-39-4)32-28(37)29-20-10-12-21(38-3)13-11-20/h5-13,18,22-24H,14-17H2,1-4H3,(H,30,33)(H,31,34)(H,35,36)(H2,29,32,37)/t22-,23-,24?/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 1n/an/an/an/a



Johnson Matthey Biomedical Research

Curated by ChEMBL


Assay Description
Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neut...


J Med Chem 39: 1013-5 (1996)


Article DOI: 10.1021/jm950908d
BindingDB Entry DOI: 10.7270/Q2TD9WF6
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM377256
PNG
(US10265310, Example 2 | rac-trans-1-(1-acetyl-4-(4...)
Show SMILES COc1ccc(cc1)[C@H]1CCN(C[C@@H]1NC(=O)Nc1ccc(Cl)cc1)C(C)=O
Show InChI InChI=1S/C21H24ClN3O3/c1-14(26)25-12-11-19(15-3-9-18(28-2)10-4-15)20(13-25)24-21(27)23-17-7-5-16(22)6-8-17/h3-10,19-20H,11-13H2,1-2H3,(H2,23,24,27)/t19-,20+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<1n/an/an/an/a



GRÜNENTHAL GMBH

US Patent


Assay Description
Cryo-vial containing 6106 cells (hFPR1-Gα15-CHO or hFPR2-Aq-CHO) was thawed in a 37 C. water bath. Cells were suspended in 10 ml of respective...


US Patent US10265310 (2019)


BindingDB Entry DOI: 10.7270/Q29S1TB4
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM377261
PNG
(US10265310, Example 7 | rac-trans-1-(4-chloropheny...)
Show SMILES COc1ccc(cc1)[C@H]1CC(=O)N(C)C[C@@H]1NC(=O)Nc1ccc(Cl)cc1
Show InChI InChI=1S/C20H22ClN3O3/c1-24-12-18(23-20(26)22-15-7-5-14(21)6-8-15)17(11-19(24)25)13-3-9-16(27-2)10-4-13/h3-10,17-18H,11-12H2,1-2H3,(H2,22,23,26)/t17-,18+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<1n/an/an/an/a



GRÜNENTHAL GMBH

US Patent


Assay Description
Cryo-vial containing 6106 cells (hFPR1-Gα15-CHO or hFPR2-Aq-CHO) was thawed in a 37 C. water bath. Cells were suspended in 10 ml of respective...


US Patent US10265310 (2019)


BindingDB Entry DOI: 10.7270/Q29S1TB4
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM377264
PNG
(US10265310, Example 10 | trans-ent1-(4-chloropheny...)
Show SMILES COc1ccc(cc1)[C@H]1CC(=O)N(C)C[C@@H]1NC(=O)Nc1ccc(Cl)cc1
Show InChI InChI=1S/C20H22ClN3O3/c1-24-12-18(23-20(26)22-15-7-5-14(21)6-8-15)17(11-19(24)25)13-3-9-16(27-2)10-4-13/h3-10,17-18H,11-12H2,1-2H3,(H2,22,23,26)/t17-,18+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<1n/an/an/an/a



GRÜNENTHAL GMBH

US Patent


Assay Description
Cryo-vial containing 6106 cells (hFPR1-Gα15-CHO or hFPR2-Aq-CHO) was thawed in a 37 C. water bath. Cells were suspended in 10 ml of respective...


US Patent US10265310 (2019)


BindingDB Entry DOI: 10.7270/Q29S1TB4
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM377266
PNG
(US10265310, Example 12 | rac-trans-1-(4-chlorophen...)
Show SMILES COc1ccc(cc1)[C@H]1CCN(C[C@@H]1NC(=O)Nc1ccc(Cl)cc1)C(=O)C1CC1
Show InChI InChI=1S/C23H26ClN3O3/c1-30-19-10-4-15(5-11-19)20-12-13-27(22(28)16-2-3-16)14-21(20)26-23(29)25-18-8-6-17(24)7-9-18/h4-11,16,20-21H,2-3,12-14H2,1H3,(H2,25,26,29)/t20-,21+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<1n/an/an/an/a



GRÜNENTHAL GMBH

US Patent


Assay Description
Cryo-vial containing 6106 cells (hFPR1-Gα15-CHO or hFPR2-Aq-CHO) was thawed in a 37 C. water bath. Cells were suspended in 10 ml of respective...


US Patent US10265310 (2019)


BindingDB Entry DOI: 10.7270/Q29S1TB4
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM377267
PNG
(US10265310, Example 13 | rac-trans-1-(4-chlorophen...)
Show SMILES COc1ccc(cc1)[C@H]1CCN(C[C@@H]1NC(=O)Nc1ccc(Cl)cc1)C(=O)CO
Show InChI InChI=1S/C21H24ClN3O4/c1-29-17-8-2-14(3-9-17)18-10-11-25(20(27)13-26)12-19(18)24-21(28)23-16-6-4-15(22)5-7-16/h2-9,18-19,26H,10-13H2,1H3,(H2,23,24,28)/t18-,19+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<1n/an/an/an/a



GRÜNENTHAL GMBH

US Patent


Assay Description
Cryo-vial containing 6106 cells (hFPR1-Gα15-CHO or hFPR2-Aq-CHO) was thawed in a 37 C. water bath. Cells were suspended in 10 ml of respective...


US Patent US10265310 (2019)


BindingDB Entry DOI: 10.7270/Q29S1TB4
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM377268
PNG
(US10265310, Example 14 | rac-trans-1-(4-chlorophen...)
Show SMILES COc1ccc(cc1)[C@H]1CCN(C[C@@H]1NC(=O)Nc1ccc(Cl)cc1)C(=O)C(C)(F)F
Show InChI InChI=1S/C22H24ClF2N3O3/c1-22(24,25)20(29)28-12-11-18(14-3-9-17(31-2)10-4-14)19(13-28)27-21(30)26-16-7-5-15(23)6-8-16/h3-10,18-19H,11-13H2,1-2H3,(H2,26,27,30)/t18-,19+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<1n/an/an/an/a



GRÜNENTHAL GMBH

US Patent


Assay Description
Cryo-vial containing 6106 cells (hFPR1-Gα15-CHO or hFPR2-Aq-CHO) was thawed in a 37 C. water bath. Cells were suspended in 10 ml of respective...


US Patent US10265310 (2019)


BindingDB Entry DOI: 10.7270/Q29S1TB4
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM377270
PNG
(US10265310, Example 16 | rac-trans-1-(4-chlorophen...)
Show SMILES COc1ccc(cc1)[C@H]1CCN(C[C@@H]1NC(=O)Nc1ccc(Cl)cc1)C(=O)C1CCOCC1
Show InChI InChI=1S/C25H30ClN3O4/c1-32-21-8-2-17(3-9-21)22-10-13-29(24(30)18-11-14-33-15-12-18)16-23(22)28-25(31)27-20-6-4-19(26)5-7-20/h2-9,18,22-23H,10-16H2,1H3,(H2,27,28,31)/t22-,23+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<1n/an/an/an/a



GRÜNENTHAL GMBH

US Patent


Assay Description
Cryo-vial containing 6106 cells (hFPR1-Gα15-CHO or hFPR2-Aq-CHO) was thawed in a 37 C. water bath. Cells were suspended in 10 ml of respective...


US Patent US10265310 (2019)


BindingDB Entry DOI: 10.7270/Q29S1TB4
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM377269
PNG
(US10265310, Example 15 | rac-trans-1-(4-chlorophen...)
Show SMILES COCCC(=O)N1CC[C@@H]([C@H](C1)NC(=O)Nc1ccc(Cl)cc1)c1ccc(OC)cc1
Show InChI InChI=1S/C23H28ClN3O4/c1-30-14-12-22(28)27-13-11-20(16-3-9-19(31-2)10-4-16)21(15-27)26-23(29)25-18-7-5-17(24)6-8-18/h3-10,20-21H,11-15H2,1-2H3,(H2,25,26,29)/t20-,21+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<1n/an/an/an/a



GRÜNENTHAL GMBH

US Patent


Assay Description
Cryo-vial containing 6106 cells (hFPR1-Gα15-CHO or hFPR2-Aq-CHO) was thawed in a 37 C. water bath. Cells were suspended in 10 ml of respective...


US Patent US10265310 (2019)


BindingDB Entry DOI: 10.7270/Q29S1TB4
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM377271
PNG
(US10265310, Example 17 | rac-trans-1-(4-chlorophen...)
Show SMILES COc1ccc(cc1)[C@H]1CCN(C[C@@H]1NC(=O)Nc1ccc(Cl)cc1)C(=O)C(C)C
Show InChI InChI=1S/C23H28ClN3O3/c1-15(2)22(28)27-13-12-20(16-4-10-19(30-3)11-5-16)21(14-27)26-23(29)25-18-8-6-17(24)7-9-18/h4-11,15,20-21H,12-14H2,1-3H3,(H2,25,26,29)/t20-,21+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<1n/an/an/an/a



GRÜNENTHAL GMBH

US Patent


Assay Description
Cryo-vial containing 6106 cells (hFPR1-Gα15-CHO or hFPR2-Aq-CHO) was thawed in a 37 C. water bath. Cells were suspended in 10 ml of respective...


US Patent US10265310 (2019)


BindingDB Entry DOI: 10.7270/Q29S1TB4
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM377272
PNG
(US10265310, Example 18 | rac-trans-1-(4-chlorophen...)
Show SMILES COc1ccc(cc1)[C@H]1CCN(C[C@@H]1NC(=O)Nc1ccc(Cl)cc1)C(=O)CC(C)C
Show InChI InChI=1S/C24H30ClN3O3/c1-16(2)14-23(29)28-13-12-21(17-4-10-20(31-3)11-5-17)22(15-28)27-24(30)26-19-8-6-18(25)7-9-19/h4-11,16,21-22H,12-15H2,1-3H3,(H2,26,27,30)/t21-,22+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<1n/an/an/an/a



GRÜNENTHAL GMBH

US Patent


Assay Description
Cryo-vial containing 6106 cells (hFPR1-Gα15-CHO or hFPR2-Aq-CHO) was thawed in a 37 C. water bath. Cells were suspended in 10 ml of respective...


US Patent US10265310 (2019)


BindingDB Entry DOI: 10.7270/Q29S1TB4
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM377275
PNG
(US10265310, Example 21 | rac-trans-methyl 2-(5-(3-...)
Show SMILES COC(=O)CN1C[C@H](NC(=O)Nc2ccc(Cl)cc2)[C@H](CC1=O)c1ccc(OC)cc1
Show InChI InChI=1S/C22H24ClN3O5/c1-30-17-9-3-14(4-10-17)18-11-20(27)26(13-21(28)31-2)12-19(18)25-22(29)24-16-7-5-15(23)6-8-16/h3-10,18-19H,11-13H2,1-2H3,(H2,24,25,29)/t18-,19+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<1n/an/an/an/a



GRÜNENTHAL GMBH

US Patent


Assay Description
Cryo-vial containing 6106 cells (hFPR1-Gα15-CHO or hFPR2-Aq-CHO) was thawed in a 37 C. water bath. Cells were suspended in 10 ml of respective...


US Patent US10265310 (2019)


BindingDB Entry DOI: 10.7270/Q29S1TB4
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM377283
PNG
(US10265310, Example 30 | rac-trans-1-(4-chlorophen...)
Show SMILES COc1ccc(cc1)[C@H]1CCN(C[C@@H]1NC(=O)Nc1ccc(Cl)cc1)C(=O)CCO
Show InChI InChI=1S/C22H26ClN3O4/c1-30-18-8-2-15(3-9-18)19-10-12-26(21(28)11-13-27)14-20(19)25-22(29)24-17-6-4-16(23)5-7-17/h2-9,19-20,27H,10-14H2,1H3,(H2,24,25,29)/t19-,20+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<1n/an/an/an/a



GRÜNENTHAL GMBH

US Patent


Assay Description
Cryo-vial containing 6106 cells (hFPR1-Gα15-CHO or hFPR2-Aq-CHO) was thawed in a 37 C. water bath. Cells were suspended in 10 ml of respective...


US Patent US10265310 (2019)


BindingDB Entry DOI: 10.7270/Q29S1TB4
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM377308
PNG
(US10265310, Example 61 | US10265310, Example 62)
Show SMILES COc1ccc(C2CC(=O)N(CC(F)F)CC2NC(=O)Nc2ccc(Cl)cc2)c(F)c1
Show InChI InChI=1S/C21H21ClF3N3O3/c1-31-14-6-7-15(17(23)8-14)16-9-20(29)28(11-19(24)25)10-18(16)27-21(30)26-13-4-2-12(22)3-5-13/h2-8,16,18-19H,9-11H2,1H3,(H2,26,27,30)
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<1n/an/an/an/a



GRÜNENTHAL GMBH

US Patent


Assay Description
Cryo-vial containing 6106 cells (hFPR1-Gα15-CHO or hFPR2-Aq-CHO) was thawed in a 37 C. water bath. Cells were suspended in 10 ml of respective...


US Patent US10265310 (2019)


BindingDB Entry DOI: 10.7270/Q29S1TB4
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM377328
PNG
(US10265310, Example 86 | trans-ent1-1-(4-chlorophe...)
Show SMILES COc1ccc([C@H]2CCN(C[C@@H]2NC(=O)Nc2ccc(Cl)cc2)C(=O)C2CC2)c(F)c1
Show InChI InChI=1S/C23H25ClFN3O3/c1-31-17-8-9-18(20(25)12-17)19-10-11-28(22(29)14-2-3-14)13-21(19)27-23(30)26-16-6-4-15(24)5-7-16/h4-9,12,14,19,21H,2-3,10-11,13H2,1H3,(H2,26,27,30)/t19-,21+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<1n/an/an/an/a



GRÜNENTHAL GMBH

US Patent


Assay Description
Cryo-vial containing 6106 cells (hFPR1-Gα15-CHO or hFPR2-Aq-CHO) was thawed in a 37 C. water bath. Cells were suspended in 10 ml of respective...


US Patent US10265310 (2019)


BindingDB Entry DOI: 10.7270/Q29S1TB4
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM50050933
PNG
((S)-2-((S)-2-{(S)-2-[3-(4-Chloro-phenyl)-ureido]-4...)
Show SMILES CSCC[C@H](NC(=O)Nc1ccc(Cl)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O
Show InChI InChI=1S/C27H35ClN4O5S/c1-17(2)15-22(25(34)31-23(26(35)36)16-18-7-5-4-6-8-18)30-24(33)21(13-14-38-3)32-27(37)29-20-11-9-19(28)10-12-20/h4-12,17,21-23H,13-16H2,1-3H3,(H,30,33)(H,31,34)(H,35,36)(H2,29,32,37)/t21-,22-,23-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 1n/an/an/an/a



Johnson Matthey Biomedical Research

Curated by ChEMBL


Assay Description
Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neut...


J Med Chem 39: 1013-5 (1996)


Article DOI: 10.1021/jm950908d
BindingDB Entry DOI: 10.7270/Q2TD9WF6
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM450338
PNG
(US10676431, Example 101)
Show SMILES CCOP(C)(=O)c1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1F
Show InChI InChI=1S/C26H24ClF3N3O4P/c1-3-37-38(2,36)22-7-5-4-6-16(22)17-9-11-21(24(30)23(17)29)33-13-12-20(25(33)34)32-26(35)31-19-10-8-15(27)14-18(19)28/h4-11,14,20H,3,12-13H2,1-2H3,(H2,31,32,35)/t20-,38?/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 1.10n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...


US Patent US10676431 (2020)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM450324
PNG
(US10676431, Example 87)
Show SMILES CP(C)(=O)c1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1OC(F)(F)F
Show InChI InChI=1S/C26H22ClF5N3O4P/c1-40(2,38)21-6-4-3-5-15(21)16-8-10-20(22(29)23(16)39-26(30,31)32)35-12-11-19(24(35)36)34-25(37)33-18-9-7-14(27)13-17(18)28/h3-10,13,19H,11-12H2,1-2H3,(H2,33,34,37)/t19-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 1.20n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...


US Patent US10676431 (2020)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM50050935
PNG
((S)-2-{(S)-4-Methyl-2-[(S)-4-methylsulfanyl-2-(3-p...)
Show SMILES CSCC[C@H](NC(=O)Nc1ccc(C)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O
Show InChI InChI=1S/C28H38N4O5S/c1-18(2)16-23(26(34)31-24(27(35)36)17-20-8-6-5-7-9-20)30-25(33)22(14-15-38-4)32-28(37)29-21-12-10-19(3)11-13-21/h5-13,18,22-24H,14-17H2,1-4H3,(H,30,33)(H,31,34)(H,35,36)(H2,29,32,37)/t22-,23-,24-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 2n/an/an/an/a



Johnson Matthey Biomedical Research

Curated by ChEMBL


Assay Description
Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neut...


J Med Chem 39: 1013-5 (1996)


Article DOI: 10.1021/jm950908d
BindingDB Entry DOI: 10.7270/Q2TD9WF6
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM450343
PNG
(US10676431, Example 106)
Show SMILES CP(C)(=O)c1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c2OC(F)(F)Oc12
Show InChI InChI=1S/C26H22ClF3N3O5P/c1-39(2,36)21-6-4-3-5-15(21)16-8-10-20(23-22(16)37-26(29,30)38-23)33-12-11-19(24(33)34)32-25(35)31-18-9-7-14(27)13-17(18)28/h3-10,13,19H,11-12H2,1-2H3,(H2,31,32,35)/t19-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 3.5n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...


US Patent US10676431 (2020)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM450325
PNG
(US10676431, Example 88)
Show SMILES CP(C)(=O)c1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(cc3F)C(F)(F)F)C2=O)c(F)c1OC(F)(F)F
Show InChI InChI=1S/C27H22F8N3O4P/c1-43(2,41)21-6-4-3-5-15(21)16-8-10-20(22(29)23(16)42-27(33,34)35)38-12-11-19(24(38)39)37-25(40)36-18-9-7-14(13-17(18)28)26(30,31)32/h3-10,13,19H,11-12H2,1-2H3,(H2,36,37,40)/t19-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 4.90n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...


US Patent US10676431 (2020)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM450358
PNG
(US10676431, Example 121 | US10676431, Example 122)
Show SMILES CC1C[C@@H](NC(=O)Nc2ccc(Cl)cc2F)C(=O)N1c1ccc(c(F)c1F)-c1cccnc1P(C)(C)=O
Show InChI InChI=1S/C25H23ClF3N4O3P/c1-13-11-19(32-25(35)31-18-8-6-14(26)12-17(18)27)24(34)33(13)20-9-7-15(21(28)22(20)29)16-5-4-10-30-23(16)37(2,3)36/h4-10,12-13,19H,11H2,1-3H3,(H2,31,32,35)/t13?,19-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 5n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...


US Patent US10676431 (2020)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM450322
PNG
(US10676431, Example 85)
Show SMILES CP(C)(=O)c1c(F)cccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1Cl
Show InChI InChI=1S/C25H21Cl2F3N3O3P/c1-37(2,36)23-15(4-3-5-16(23)28)14-7-9-20(22(30)21(14)27)33-11-10-19(24(33)34)32-25(35)31-18-8-6-13(26)12-17(18)29/h3-9,12,19H,10-11H2,1-2H3,(H2,31,32,35)/t19-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 5.10n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...


US Patent US10676431 (2020)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM450344
PNG
(US10676431, Example 107)
Show SMILES CP(C)(=O)c1ccccc1-c1ccc(c([H]C(F)F)c1F)N1CC[C@@H](NC(=O)Nc2ccc(Cl)cc2F)C1=O
Show InChI InChI=1S/C26H24ClF4N3O3P/c1-38(2,37)21-6-4-3-5-15(21)16-8-10-20(23(22(16)29)39-25(30)31)34-12-11-19(24(34)35)33-26(36)32-18-9-7-14(27)13-17(18)28/h3-10,13,19,25H,11-12H2,1-2H3,(H2,32,33,36)/t19-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 5.80n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...


US Patent US10676431 (2020)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM50513095
PNG
(CHEMBL4532583)
Show SMILES CCCCC(C(=O)Nc1ccc(Br)cc1)n1nc(C)cc(Cc2cccc(OC)c2OC)c1=O
Show InChI InChI=1S/C26H30BrN3O4/c1-5-6-9-22(25(31)28-21-13-11-20(27)12-14-21)30-26(32)19(15-17(2)29-30)16-18-8-7-10-23(33-3)24(18)34-4/h7-8,10-15,22H,5-6,9,16H2,1-4H3,(H,28,31)
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
Article
PubMed
n/an/an/an/a 6.5n/an/an/an/a



Monash University

Curated by ChEMBL


Assay Description
Biased agonist activity at human FPR1 expressed in FlpIn-CHO cells assessed as intracellular calcium mobilization by Fluo-4-AM dye based fluorescence...


J Med Chem 62: 5242-5248 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01912
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM50295526
PNG
(CHEMBL564392 | N-(4-Bromophenyl)-2-[5-(3-methoxybe...)
Show SMILES COc1cccc(Cc2cc(C)nn(C(C)C(=O)Nc3ccc(Br)cc3)c2=O)c1
Show InChI InChI=1S/C22H22BrN3O3/c1-14-11-17(12-16-5-4-6-20(13-16)29-3)22(28)26(25-14)15(2)21(27)24-19-9-7-18(23)8-10-19/h4-11,13,15H,12H2,1-3H3,(H,24,27)
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 8n/an/an/an/a



Universita degli Studi di Firenze

Curated by ChEMBL


Assay Description
Agonist activity at FPR1 in human neutrophiles by chemotaxis assay


J Med Chem 52: 5044-57 (2010)


Article DOI: 10.1021/jm900592h
BindingDB Entry DOI: 10.7270/Q2WS8T85
More data for this
Ligand-Target Pair
N-formyl peptide receptor 1


(Homo sapiens (Human))
BDBM454189
PNG
(US10717708, Example 77)
Show SMILES OCc1ccccc1-c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(Cl)cc2)C1=O
Show InChI InChI=1S/C25H24ClN3O3/c26-19-9-11-20(12-10-19)27-25(32)28-23-6-3-15-29(24(23)31)21-13-7-17(8-14-21)22-5-2-1-4-18(22)16-30/h1-2,4-5,7-14,23,30H,3,6,15-16H2,(H2,27,28,32)/t23-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 8.80n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US10717708 (2020)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 1


(Homo sapiens (Human))
BDBM454188
PNG
(US10717708, Example 76)
Show SMILES Clc1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)-c2ccccc2C#N)cc1
Show InChI InChI=1S/C25H21ClN4O2/c26-19-9-11-20(12-10-19)28-25(32)29-23-6-3-15-30(24(23)31)21-13-7-17(8-14-21)22-5-2-1-4-18(22)16-27/h1-2,4-5,7-14,23H,3,6,15H2,(H2,28,29,32)/t23-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 10n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US10717708 (2020)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM50050937
PNG
((S)-2-[(S)-2-((S)-2-Formylamino-4-methylsulfanyl-b...)
Show SMILES CSCC[C@H](NC=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O
Show InChI InChI=1S/C21H31N3O5S/c1-14(2)11-17(23-19(26)16(22-13-25)9-10-30-3)20(27)24-18(21(28)29)12-15-7-5-4-6-8-15/h4-8,13-14,16-18H,9-12H2,1-3H3,(H,22,25)(H,23,26)(H,24,27)(H,28,29)/t16-,17-,18-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
Purchase

CHEBI
CHEMBL
KEGG
MMDB
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 10n/an/an/an/a



Universita degli Studi di Firenze

Curated by ChEMBL


Assay Description
Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assay


J Med Chem 52: 5044-57 (2010)


Article DOI: 10.1021/jm900592h
BindingDB Entry DOI: 10.7270/Q2WS8T85
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM50295518
PNG
(2-[5-(3-Methoxybenzyl)-3-methyl-6-oxo-6H-pyridazin...)
Show SMILES COc1ccc(NC(=O)Cn2nc(C)cc(Cc3cccc(OC)c3)c2=O)cc1
Show InChI InChI=1S/C22H23N3O4/c1-15-11-17(12-16-5-4-6-20(13-16)29-3)22(27)25(24-15)14-21(26)23-18-7-9-19(28-2)10-8-18/h4-11,13H,12,14H2,1-3H3,(H,23,26)
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 11n/an/an/an/a



Universita degli Studi di Firenze

Curated by ChEMBL


Assay Description
Agonist activity at FPR1 in human neutrophiles by chemotaxis assay


J Med Chem 52: 5044-57 (2010)


Article DOI: 10.1021/jm900592h
BindingDB Entry DOI: 10.7270/Q2WS8T85
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM450331
PNG
(US10676431, Example 94)
Show SMILES CP(C)(=O)c1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(cc3F)C(F)(F)F)C2=O)c(F)c1C(F)(F)F
Show InChI InChI=1S/C27H22F8N3O3P/c1-42(2,41)21-6-4-3-5-15(21)16-8-10-20(23(29)22(16)27(33,34)35)38-12-11-19(24(38)39)37-25(40)36-18-9-7-14(13-17(18)28)26(30,31)32/h3-10,13,19H,11-12H2,1-2H3,(H2,36,37,40)/t19-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 12n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...


US Patent US10676431 (2020)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 1


(Homo sapiens (Human))
BDBM454191
PNG
(US10717708, Example 82)
Show SMILES Clc1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)-c2c(Cl)cccc2Cl)cc1
Show InChI InChI=1S/C24H20Cl3N3O2/c25-16-8-10-17(11-9-16)28-24(32)29-21-5-2-14-30(23(21)31)18-12-6-15(7-13-18)22-19(26)3-1-4-20(22)27/h1,3-4,6-13,21H,2,5,14H2,(H2,28,29,32)/t21-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 14n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US10717708 (2020)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 1


(Homo sapiens (Human))
BDBM454196
PNG
(US10717708, Example 145)
Show SMILES CN(c1ncccc1-c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O)S(C)(=O)=O
Show InChI InChI=1S/C26H26F3N5O4S/c1-33(39(2,37)38)23-21(5-3-15-30-23)17-7-13-20(14-8-17)34-16-4-6-22(24(34)35)32-25(36)31-19-11-9-18(10-12-19)26(27,28)29/h3,5,7-15,22H,4,6,16H2,1-2H3,(H2,31,32,36)/t22-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 15n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US10717708 (2020)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM50295517
PNG
(2-[5-(3-Methoxybenzyl)-3-methyl-6-oxo-6H-pyridazin...)
Show SMILES COc1cccc(Cc2cc(C)nn(CC(=O)Nc3ccc(C)cc3)c2=O)c1
Show InChI InChI=1S/C22H23N3O3/c1-15-7-9-19(10-8-15)23-21(26)14-25-22(27)18(11-16(2)24-25)12-17-5-4-6-20(13-17)28-3/h4-11,13H,12,14H2,1-3H3,(H,23,26)
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 16n/an/an/an/a



Universita degli Studi di Firenze

Curated by ChEMBL


Assay Description
Agonist activity at FPR1 in human neutrophiles by chemotaxis assay


J Med Chem 52: 5044-57 (2010)


Article DOI: 10.1021/jm900592h
BindingDB Entry DOI: 10.7270/Q2WS8T85
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM50295517
PNG
(2-[5-(3-Methoxybenzyl)-3-methyl-6-oxo-6H-pyridazin...)
Show SMILES COc1cccc(Cc2cc(C)nn(CC(=O)Nc3ccc(C)cc3)c2=O)c1
Show InChI InChI=1S/C22H23N3O3/c1-15-7-9-19(10-8-15)23-21(26)14-25-22(27)18(11-16(2)24-25)12-17-5-4-6-20(13-17)28-3/h4-11,13H,12,14H2,1-3H3,(H,23,26)
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 16n/an/an/an/a



Universita degli Studi di Firenze

Curated by ChEMBL


Assay Description
Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assay


J Med Chem 52: 5044-57 (2010)


Article DOI: 10.1021/jm900592h
BindingDB Entry DOI: 10.7270/Q2WS8T85
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM450366
PNG
(US10676431, Example 129)
Show SMILES CC1C[C@@H](NC(=O)Nc2ccc(Cl)cc2F)C(=O)N1c1ccc(c(F)c1F)-c1ccccc1S(C)(=O)=O
Show InChI InChI=1S/C25H21ClF3N3O4S/c1-13-11-19(31-25(34)30-18-9-7-14(26)12-17(18)27)24(33)32(13)20-10-8-16(22(28)23(20)29)15-5-3-4-6-21(15)37(2,35)36/h3-10,12-13,19H,11H2,1-2H3,(H2,30,31,34)/t13?,19-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 19n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...


US Patent US10676431 (2020)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM450307
PNG
(US10676431, Example 70)
Show SMILES CP(C)(=O)c1c(F)cccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1F
Show InChI InChI=1S/C25H21ClF4N3O3P/c1-37(2,36)23-15(4-3-5-16(23)27)14-7-9-20(22(30)21(14)29)33-11-10-19(24(33)34)32-25(35)31-18-8-6-13(26)12-17(18)28/h3-9,12,19H,10-11H2,1-2H3,(H2,31,32,35)/t19-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 20n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...


US Patent US10676431 (2020)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM50050937
PNG
((S)-2-[(S)-2-((S)-2-Formylamino-4-methylsulfanyl-b...)
Show SMILES CSCC[C@H](NC=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O
Show InChI InChI=1S/C21H31N3O5S/c1-14(2)11-17(23-19(26)16(22-13-25)9-10-30-3)20(27)24-18(21(28)29)12-15-7-5-4-6-8-15/h4-8,13-14,16-18H,9-12H2,1-3H3,(H,22,25)(H,23,26)(H,24,27)(H,28,29)/t16-,17-,18-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
Purchase

CHEBI
CHEMBL
KEGG
MMDB
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 20n/an/an/an/a



Johnson Matthey Biomedical Research

Curated by ChEMBL


Assay Description
Agonistic activity was determined by measuring the ability to induce superoxide production(as measured by reduction of cytochrome C) using human neut...


J Med Chem 39: 1013-5 (1996)


Article DOI: 10.1021/jm950908d
BindingDB Entry DOI: 10.7270/Q2TD9WF6
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM450323
PNG
(US10676431, Example 86)
Show SMILES CP(C)(=O)c1c(F)cccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(cc3F)C(F)(F)F)C2=O)c(F)c1Cl
Show InChI InChI=1S/C26H21ClF6N3O3P/c1-40(2,39)23-15(4-3-5-16(23)28)14-7-9-20(22(30)21(14)27)36-11-10-19(24(36)37)35-25(38)34-18-8-6-13(12-17(18)29)26(31,32)33/h3-9,12,19H,10-11H2,1-2H3,(H2,34,35,38)/t19-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 21n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...


US Patent US10676431 (2020)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM450357
PNG
(US10676431, Example 120 | US10676431, Example 128)
Show SMILES CC1C[C@@H](NC(=O)Nc2ccc(cc2F)C(F)(F)F)C(=O)N1c1ccc(c(F)c1F)-c1cccnc1P(C)(C)=O
Show InChI InChI=1S/C26H23F6N4O3P/c1-13-11-19(35-25(38)34-18-8-6-14(12-17(18)27)26(30,31)32)24(37)36(13)20-9-7-15(21(28)22(20)29)16-5-4-10-33-23(16)40(2,3)39/h4-10,12-13,19H,11H2,1-3H3,(H2,34,35,38)/t13?,19-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 24n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...


US Patent US10676431 (2020)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM450326
PNG
(US10676431, Example 89)
Show SMILES CP(C)(=O)c1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(cc3F)C(F)(F)F)C2=O)c(F)c1C1CC1
Show InChI InChI=1S/C29H27F5N3O3P/c1-41(2,40)24-6-4-3-5-18(24)19-10-12-23(26(31)25(19)16-7-8-16)37-14-13-22(27(37)38)36-28(39)35-21-11-9-17(15-20(21)30)29(32,33)34/h3-6,9-12,15-16,22H,7-8,13-14H2,1-2H3,(H2,35,36,39)/t22-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 25n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...


US Patent US10676431 (2020)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 1


(Homo sapiens (Human))
BDBM454204
PNG
(US10717708, Example 188)
Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(Cl)cc2F)C1=O
Show InChI InChI=1S/C25H24ClFN4O4S/c1-36(34,35)30-21-6-3-2-5-19(21)16-8-11-18(12-9-16)31-14-4-7-23(24(31)32)29-25(33)28-22-13-10-17(26)15-20(22)27/h2-3,5-6,8-13,15,23,30H,4,7,14H2,1H3,(H2,28,29,33)/t23-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/an/an/a 25n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US10717708 (2020)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM50295524
PNG
(CHEMBL551589 | N-(4-Bromophenyl)-2-[5-(3-methoxybe...)
Show SMILES COc1cccc(Cc2cc(C)nn(CC(=O)Nc3ccc(Br)cc3)c2=O)c1
Show InChI InChI=1S/C21H20BrN3O3/c1-14-10-16(11-15-4-3-5-19(12-15)28-2)21(27)25(24-14)13-20(26)23-18-8-6-17(22)7-9-18/h3-10,12H,11,13H2,1-2H3,(H,23,26)
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 26n/an/an/an/a



Universita degli Studi di Firenze

Curated by ChEMBL


Assay Description
Agonist activity at FPR1 in human neutrophiles assessed as induction of intracellular calcium flux by FLIPR3 calcium assay


J Med Chem 52: 5044-57 (2010)


Article DOI: 10.1021/jm900592h
BindingDB Entry DOI: 10.7270/Q2WS8T85
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM450271
PNG
(US10676431, Example 34)
Show SMILES COc1c(F)c(ccc1-c1ccccc1NS(C)(=O)=O)N1CC[C@@H](NC(=O)Nc2ccc(Cl)cc2F)C1=O
Show InChI InChI=1S/C25H23ClF2N4O5S/c1-37-23-16(15-5-3-4-6-18(15)31-38(2,35)36)8-10-21(22(23)28)32-12-11-20(24(32)33)30-25(34)29-19-9-7-14(26)13-17(19)27/h3-10,13,20,31H,11-12H2,1-2H3,(H2,29,30,34)/t20-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 26n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...


US Patent US10676431 (2020)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM50295514
PNG
(CHEMBL556625 | N-(4-Chlorophenyl)-2-[5-(3-methoxyb...)
Show SMILES COc1cccc(Cc2cc(C)nn(CC(=O)Nc3ccc(Cl)cc3)c2=O)c1
Show InChI InChI=1S/C21H20ClN3O3/c1-14-10-16(11-15-4-3-5-19(12-15)28-2)21(27)25(24-14)13-20(26)23-18-8-6-17(22)7-9-18/h3-10,12H,11,13H2,1-2H3,(H,23,26)
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 26n/an/an/an/a



Universita degli Studi di Firenze

Curated by ChEMBL


Assay Description
Agonist activity at FPR1 expressed in human HL60 cells assessed as induction of intracellular calcium flux by FLIPR3 calcium assay


J Med Chem 52: 5044-57 (2010)


Article DOI: 10.1021/jm900592h
BindingDB Entry DOI: 10.7270/Q2WS8T85
More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM450318
PNG
(US10676431, Example 81)
Show SMILES CP(C)(=O)c1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1Cl
Show InChI InChI=1S/C25H22Cl2F2N3O3P/c1-36(2,35)21-6-4-3-5-15(21)16-8-10-20(23(29)22(16)27)32-12-11-19(24(32)33)31-25(34)30-18-9-7-14(26)13-17(18)28/h3-10,13,19H,11-12H2,1-2H3,(H2,30,31,34)/t19-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 27n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...


US Patent US10676431 (2020)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM450369
PNG
(US10676431, Example 132)
Show SMILES CP(C)(=O)c1ccccc1-c1ccc(N2CC3(CC3)[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1F
Show InChI InChI=1S/C27H24ClF3N3O3P/c1-38(2,37)21-6-4-3-5-16(21)17-8-10-20(23(31)22(17)30)34-14-27(11-12-27)24(25(34)35)33-26(36)32-19-9-7-15(28)13-18(19)29/h3-10,13,24H,11-12,14H2,1-2H3,(H2,32,33,36)/t24-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 28n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...


US Patent US10676431 (2020)

More data for this
Ligand-Target Pair
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM50295515
PNG
(CHEMBL560780 | N-(4-Iodophenyl)-2-[5-(3-methoxyben...)
Show SMILES COc1cccc(Cc2cc(C)nn(CC(=O)Nc3ccc(I)cc3)c2=O)c1
Show InChI InChI=1S/C21H20IN3O3/c1-14-10-16(11-15-4-3-5-19(12-15)28-2)21(27)25(24-14)13-20(26)23-18-8-6-17(22)7-9-18/h3-10,12H,11,13H2,1-2H3,(H,23,26)
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 28n/an/an/an/a



Universita degli Studi di Firenze

Curated by ChEMBL


Assay Description
Agonist activity at FPR1 expressed in human HL60 cells assessed as induction of intracellular calcium flux by FLIPR3 calcium assay


J Med Chem 52: 5044-57 (2010)


Article DOI: 10.1021/jm900592h
BindingDB Entry DOI: 10.7270/Q2WS8T85
More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 1285 total )  |  Next  |  Last  >>
Jump to: